Should you buy shares in National Australia Bank Ltd. and QBE Insurance Group Ltd?

Do these 2 stocks have high total return potential? National Australia Bank Ltd. (ASX:NAB) and QBE Insurance Group Ltd (ASX:QBE)

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Two financial stocks which are undergoing major changes are National Australia Bank Ltd. (ASX: NAB) and QBE Insurance Group Ltd (ASX: QBE). Both companies have endured rather challenging periods in recent years but, with changes being made to their business models, they could be on the cusp of improved financial performance.

In NAB's case, its international operations have been a cause for concern for a number of years, with its UK subsidiaries Clydesdale and Yorkshire Bank causing disappointment for NAB's investors. For example, they have been forced to make provisions for the seemingly never-ending payment protection insurance (PPI) claims, which are not yet at a close. As such, NAB's decision to offload the struggling divisions plus its 28.5% stake in US-based Great Western Bank will allow it to focus on core activities and generate improved performance and efficiencies within more favourable product areas.

Furthermore, NAB has strengthened its balance sheet via a capital raising. The bank's common equity tier 1 ratio now stands at just below 10%, which is a 1.07% improvement on a year ago. This should allow it to face the challenging economic circumstances in which the Australian economy finds itself, while NAB's dividend yield of 6.5% (fully franked) will provide the bank's investors with an impressive level of cash flow while the bank seeks to improve its financial performance.

That said, NAB is forecast to increase its bottom line at an annualised rate of almost 9% during the next two years. And, with its shares trading on a price to earnings (P/E) ratio of 13.4 versus 15.9 for the ASX, an upward rerating could be on the cards.

Meanwhile, QBE is also in the process of refreshing its business model, with a number of non-core assets having been sold off as the insurer aims to become a leaner, more focused and more profitable entity. It seems to be making encouraging progress on this front, with its bottom line expected to rise by 58% over the next two financial years. And, as with NAB, it trades at a discount to the ASX, with QBE having a P/E ratio of 15.3.

A key part of QBE's growth plans is to improve its penetration in emerging markets, as well as provide an improved multi-channel distribution approach in Australia and New Zealand. Furthermore, with QBE being on target to post a total run rate of savings of $450m by the end of the 2016 financial year, its margins are likely to improve over the coming years, too.

Clearly, the market is backing QBE's turnaround plan, with the company's shares having bucked the wider trend to rise by 17% since the turn of the year. And, with a beta of less than 0.6, QBE offers relative stability even during a period of change for the business. Therefore, alongside NAB, it appears to be a strong buy right now.

Motley Fool contributor Peter Stephens has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »